Dellora Investments Master Fund LP 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 2:21 pm Purchase |
2024-11-06 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 141,079 10.700% |
32,105 (+29.46%) |
Filing |
| 2024-08-07 2:16 pm Purchase |
2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 108,974 8.300% |
108,974 (New Position) |
Filing |